Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review

Oligometastatic (OM) disease is defined by a low metastatic tumor spread. OM non-small cell lung cancer (NSCLC) treatment aims to improve the patient’s prognosis and quality of life, in an attempt-to-cure objective. Oncogenic-driven metastatic NSCLC accounts for about 20–25% of NSCLCs, with an ever-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallet, Vincent, Matton, Lise, Schernberg, Antoine, Canellas, Anthony, Cornelis, François H., Cadranel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350076/
https://www.ncbi.nlm.nih.gov/pubmed/34430380
http://dx.doi.org/10.21037/tlcr-20-1152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350076/
https://www.ncbi.nlm.nih.gov/pubmed/34430380
http://dx.doi.org/10.21037/tlcr-20-1152

Ejemplares similares